SG Americas Securities’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-17,818
| Closed | -$102K | – | 2519 |
|
2025
Q1 | $102K | Sell |
17,818
-4,547
| -20% | -$26K | ﹤0.01% | 2691 |
|
2024
Q4 | $112K | Buy |
22,365
+2,822
| +14% | +$14.1K | ﹤0.01% | 2363 |
|
2024
Q3 | $105K | Buy |
19,543
+8,165
| +72% | +$43.9K | ﹤0.01% | 2693 |
|
2024
Q2 | $38K | Buy |
+11,378
| New | +$38K | ﹤0.01% | 2339 |
|
2024
Q1 | – | Sell |
-11,028
| Closed | -$39K | – | 2543 |
|
2023
Q4 | $39K | Buy |
+11,028
| New | +$39K | ﹤0.01% | 2670 |
|
2021
Q4 | – | Sell |
-17,348
| Closed | -$152K | – | 2938 |
|
2021
Q3 | $152K | Buy |
+17,348
| New | +$152K | ﹤0.01% | 3155 |
|
2021
Q1 | – | Sell |
-26,578
| Closed | -$182K | – | 2888 |
|
2020
Q4 | $182K | Buy |
+26,578
| New | +$182K | ﹤0.01% | 2358 |
|
2018
Q4 | – | Sell |
-94,269
| Closed | -$1.3M | – | 2436 |
|
2018
Q3 | $1.3M | Buy |
+94,269
| New | +$1.3M | 0.01% | 1340 |
|